Colby Pharmaceutical Co-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Colby Pharmaceutical Co - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013078
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Colby Pharmaceutical Company (Colby Pharma) is a biopharma company that focuses on the development of safe and effective small molecule analgesic, anti-inflammatory drug, and immunobiologic products. Its product portfolio includes Oral small molecule analgesics CPC-123 & CPC-111 for post-surgical, muscular, headache, neuropathic, and/or cancer pain; OT-551 for smoking-related and age-related macular degeneration; CPC-888 biologic products for allergic conjunctivitis and allergic rhinitis control and cure and MKC-1106 & CPC-1207 biologic and SIL device products for control and/or long-term durable remission of malignant melanoma or disseminated lymphoma. The company uses its proprietary platform technology CPC ILNI for allergy desensitization, cancer immunotherapy and infectious disease vaccination. Colby Pharma is headquartered in Menlo Park, California, the US.

Colby Pharmaceutical Co – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Colby Pharmaceutical Co, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Colby Pharmaceutical Co, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Colby Pharmaceutical Co, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Colby Pharmaceutical Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Colby Pharmaceutical Co, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Colby Pharmaceutical Co, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Colby Enters Into Licensing Agreement With MannKind For Cancer Immunotherapy Products 10
Juvaris Enters Into Licensing Agreement With Colby Pharma For JVRS-100 And CLDC Technology 12
Acquisition 13
Colby Pharma Acquires Othera Pharma, Developer Of Drugs For Ophthalmic Diseases 13
Colby Pharmaceutical Co – Key Competitors 14
Colby Pharmaceutical Co – Key Employees 15
Colby Pharmaceutical Co – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Colby Pharmaceutical Co, Pharmaceuticals & Healthcare, Key Facts 2
Colby Pharmaceutical Co, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Colby Pharmaceutical Co, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Colby Pharmaceutical Co, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Colby Pharmaceutical Co, Deals By Therapy Area, 2011 to YTD 2017 8
Colby Pharmaceutical Co, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Colby Enters Into Licensing Agreement With MannKind For Cancer Immunotherapy Products 10
Juvaris Enters Into Licensing Agreement With Colby Pharma For JVRS-100 And CLDC Technology 12
Colby Pharma Acquires Othera Pharma, Developer Of Drugs For Ophthalmic Diseases 13
Colby Pharmaceutical Co, Key Competitors 14
Colby Pharmaceutical Co, Key Employees 15

★海外企業調査レポート[Colby Pharmaceutical Co-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Equity Assurance plc:企業の戦略・SWOT・財務情報
    Equity Assurance plc - Strategy, SWOT and Corporate Finance Report Summary Equity Assurance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Biosense Webster Inc-医療機器分野:企業M&A・提携分析
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson is a medical device company that offers cardiac arrhythmias products. The company designs, manufactures and markets products for diagnosis and treatment of cardiac arrhythmias. Its products comprise ablation catheters …
  • Sequana SA (SEQ):企業の財務・戦略的SWOT分析
    Sequana SA (SEQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Salk Institute for Biological Studies-製薬・医療分野:企業M&A・提携分析
    Summary Salk Institute for Biological Studies (Salk) is a research institute that offers biological research programs. The institute’s areas of research comprise molecular biology and genetics, neurosciences, and plant biology. Its research provides development of new therapies and treatments for di …
  • Intuitive Surgical Inc (ISRG):企業の財務・戦略的SWOT分析
    Intuitive Surgical Inc (ISRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Swisscom Ltd (SCMN):企業の財務・戦略的SWOT分析
    Swisscom Ltd (SCMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Toyota Industries Corporation (6201):企業の財務・戦略的SWOT分析
    Toyota Industries Corporation (6201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Principal Financial Group Inc:企業の戦略・SWOT・財務情報
    Principal Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Principal Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Emory Healthcare Corporate:製薬・医療:M&Aディール及び事業提携情報
    Summary Emory Healthcare Corporate (Emory Healthcare) is a healthcare service provider. The center offers treatments such as acl injuries, aging, als and related conditions, bleeding disorders, bone and tissue tumors, brain health, cancer conditions, dental implants, dermatology, digestive diseases; …
  • DiaMedica Therapeutics Inc (DMA):企業の財務・戦略的SWOT分析
    Summary DiaMedica Therapeutics Inc (DiaMedica) formerly DiaMedica Inc, is a clinical-stage bio pharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 …
  • DFDS AS (DFDS):企業の財務・戦略的SWOT分析
    DFDS AS (DFDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Lonestar Heart Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lonestar Heart Inc (Lonestar Heart) is a pharmaceutical company that focuses on the development of novel cardiac restorative therapies for advanced heart failure. The company offers Algisyl cardiac implantable hydrogel and MyoTec system. Its Algisyl product provides a new treatment option fo …
  • Tecpetrol SA:企業の戦略的SWOT分析
    Tecpetrol SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • NAPEC Inc:電力:M&Aディール及び事業提携情報
    Summary NAPEC Inc (NAPEC), is a subsidiary of Oaktree Capital Management, L.P., is an energy services company that provides construction and maintenance services. It builds and maintains electrical transmission and distribution systems, solar panel farms, and natural gas networks. The company instal …
  • WorleyParsons Ltd (WOR):企業の財務・戦略的SWOT分析
    WorleyParsons Ltd (WOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • The Williams Companies, Inc.:企業の戦略・SWOT・財務分析
    The Williams Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Williams Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Terumo Corporation:企業の戦略・SWOT・財務情報
    Terumo Corporation - Strategy, SWOT and Corporate Finance Report Summary Terumo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Savola Group Co:企業の戦略・SWOT・財務情報
    Savola Group Co - Strategy, SWOT and Corporate Finance Report Summary Savola Group Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Allscripts Healthcare Solutions, Inc.:企業の戦略・SWOT・財務分析
    Allscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Allscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • BioVendor – Laboratorni Medicina as-製薬・医療分野:企業M&A・提携分析
    Summary BioVendor - Laboratorni Medicina as (BioVendor) is a developer and manufacturer of immunoassays, recombinant protiens, antibodies and endotoxin-removal products. The company’s products include immunoassays, proteins, antibodies, endotoxin removal products, endotoxin detection products, immun …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆